AI assistant
AMGEN INC — Director's Dealing 2025
Nov 13, 2025
29819_dirs_2025-11-12_478d1831-8d92-43a1-9998-b48bc4610777.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2025-11-11
Reporting Person: REESE DAVID M (EVP & Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | Common Stock | G | 6490 | — | Disposed | 35812 | Direct |
| 2025-11-12 | Common Stock | G | 309 | — | Disposed | 35503 | Direct |
Footnotes
F1: The transaction reported involved a gift by the reporting person of shares of the Company's common stock to a charitable donor advised fund.
F2: The transaction reported involved a gift by the reporting person of shares of the Company's common stock to a non-profit charitable organization.
F3: These shares include 583 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.